| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $62.4M | +48.3% |
| R&D Expense | $132.2M | -8.2% |
| SG&A Expense | $41.5M | -5.1% |
| Operating Income | -$111.3M | +23.6% |
| Pre-tax Income | -$101.6M | +21.9% |
| Income Tax | $4K | -98.1% |
| Net Income | -$101.6M | +22.0% |
| EPS (Basic) | -$0.87 | +26.9% |
| EPS (Diluted) | -$0.87 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.3M | +61.5% |
| Short-term Investments | $230.9M | +22.5% |
| Current Assets | $353.8M | +32.8% |
| Total Assets | $398.7M | +26.0% |
| Current Liabilities | $21.7M | -43.2% |
| Total Liabilities | $52.5M | -55.1% |
| Stockholders' Equity | $346.2M | +73.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$138.9M | -5.6% |
| Capital Expenditures | $1.0M | +39.0% |
| Investing Cash Flow | -$40.9M | -147.4% |
| Financing Cash Flow | $222.5M | +366.8% |
| Free Cash Flow | -$139.9M | -5.8% |
| +26.9% |